3-(dipropylamino)tetralin-5-ol
ADVERTISEMENT
- Molecular formula
- C17H29NO
- CAS Number
- 107198-79-8
- IUPAC Name
- 3-(dipropylamino)tetralin-5-ol
- Molecular Weight
- 261.42g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.0633g/cm3
- Appearance
- without any suspended particles or turbidity.
- Synonyms
- 8-OH-Dpat
Identification
Interesting facts
Interesting Facts About 3-(Dipropylamino)tetralin-5-ol
3-(Dipropylamino)tetralin-5-ol, a fascinating compound, has sparked interest in various fields due to its unique structure and potential applications. Here are some captivating insights:
- Structural Complexity: The presence of the dipropylamino group attached to the tetralin core introduces a remarkable level of structural diversity. This complexity can lead to varied interactions with biological systems.
- Potential Pharmacological Applications: Due to its structural composition, 3-(dipropylamino)tetralin-5-ol is an intriguing candidate for drug discovery, particularly in the realm of neuropharmacology. Compounds similar to this have been investigated for their effects on the central nervous system.
- Synthesis Considerations: The synthesis of this compound can take advantage of various organic reactions such as amination and hydroxylation processes. Understanding these pathways helps chemists to design more efficient synthetic routes.
- Research Relevance: Studies often explore the selectivity and binding characteristics of such compounds with neurotransmitter receptors, like dopamine or serotonin, which can elucidate their behavior in pharmacological contexts.
- Analytical Techniques: Characterizing this compound may involve advanced analytical methods, such as NMR (Nuclear Magnetic Resonance) spectroscopy and mass spectrometry, enabling chemists to confirm its structure and investigate its properties.
In summary, 3-(dipropylamino)tetralin-5-ol serves as more than just a chemical entity; it embodies the marriage of organic chemistry with medicinal research, showcasing the intricate dance between structure and function in the quest for new therapeutic agents.